T Cell News and Research

Latest T Cell News and Research

DSM Biologics partners with Australian Governments to build cGMP mammalian CMO

DSM Biologics is pleased to announce the signing of preliminary agreements to enter a partnership with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate the first major Australia-based mammalian biopharmaceutical manufacturing facility, which will be located in Brisbane.

3 May 2010

Celgene seeks court declaration over claims of romidepsin injection usage for T-cell lymphomas

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.

3 May 2010

Roche's xCELLigence System helps study cell viability, cell death while testing cytotoxic compounds

Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.

3 May 2010

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

The first trial of an important new combination therapy of treatment with the chemotherapy drug pemetrexed concurrent with radiation in lung cancer has delivered promising results, French researchers report at the 2nd European Lung Cancer Conference.

3 May 2010

Dieters who change their surroundings can easily adhere to diet: Researchers

According to a new finding by a team of Cornell University researchers, dieters who focus on changing their surroundings find it easier to adhere to their diet. Understandably, they also report losing the most weight.

3 May 2010

Parents administering highly complex medication regimens require additional supports

Parents of children with chronic conditions make many mistakes when giving lifesaving medicines, according to a study being presented Monday, May 3 at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

PAS conference focuses on vaccine-preventable diseases among children

Each year, millions of children in developing countries die from diseases for which known treatments exist. How to use this knowledge to save children's lives on a global scale will be discussed in a day-long session Monday, May 3, 2010, at the Pediatric Academic Societies (PAS) meeting in Vancouver, British Columbia, Canada.

3 May 2010

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

Results from the VeriStrat biomarker analysis of a multicenter Phase III trial were presented today at the 2nd European Lung Cancer Conference currently being held in Geneva, Switzerland. Results showed that the VeriStrat test identified patients who were likely to have a survival benefit from treatment with erlotinib, a commonly prescribed oral therapy for advanced non-small cell lung cancer.

3 May 2010

ZIOPHARM reports a net loss of $17.7 million in first quarter 2010

ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, today reported its financial results for the three months ended March 31, 2010 and updated the Company's continued progress with its clinical programs.

3 May 2010

Researchers discover a new driving force behind cancer growth

Researchers from the University of Leeds, UK, the Charit- University Medical School and the Max Delbr-ck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force behind cancer growth.

3 May 2010

Molecular imaging can help physicians identify aortic dissection: Research

According to research published in the May issue of The Journal of Nuclear Medicine, molecular imaging can help physicians identify aortic dissection-an often fatal blood vessel condition-and help guide treatment.

3 May 2010

Mutations in several genes associated with developmental brain disorder: Study

Although there is no known cause of autism, studies have shown that mutations in several genes are associated with the developmental brain disorder. New research has uncovered two additional genes that may be involved with autism.

3 May 2010

McGill scientist discovers how one particular gene regulates epithelial cells

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in strange ways (photos available) and sometimes become cancer tumors. With the support of Chen Ling and Dongmei Zuo at McGill's Goodman Cancer Centre, Muller has discovered how one particular gene regulates epithelial cells - cells that normally form in sheets and are polarized to enable the transport of molecules in a single direction.

30 Apr 2010

Research shows microRNA can silence genes that protect genome from cancer-causing mutations

New research shows for the first time that molecules called microRNA can silence genes that protect the genome from cancer-causing mutations.

30 Apr 2010

Accelerated radiotherapy improves overall survival of patient with NSCLC: Report

A new meta-analysis reported at the second European Lung Cancer Conference shows that patients with both non-small-cell lung cancer and small-cell lung cancer benefit in terms of overall survival when treated with hyperfractionated or accelerated radiotherapy.

30 Apr 2010

Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

Pieris AG announced today preclinical data for its proprietary PRS-110 Anticalin compound, which targets the c-Met receptor, demonstrating a dose-dependant reduction of tumor growth in a xenograft mouse model.

30 Apr 2010

Neuralstem's stem cell treatment for ALS featured on CNN with Dr. Sanjay Gupta

Neuralstem, Inc. announced that its stem cell treatment for ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease), currently in a FDA-approved Phase I clinical trial, was featured on CNN last night with Dr. Sanjay Gupta, in the piece entitled "Stem Cell Medical Breakthrough".

30 Apr 2010

Stanford University's Herzenberg Lab wins 2010 Laureate in Computerworld Honors Program

Stanford University's Herzenberg Laboratory is a 2010 Laureate in the prestigious Computerworld Honors Program. SAS, the leader in business analytics software and services, announced the award today.

30 Apr 2010

Liver transplant recipients develop premature immune senescence: Researchers

Researchers at the University of Cambridge found that liver transplant recipients develop premature immune senescence, the normal process by which the immune system ages and becomes less effective. Full details appear in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

30 Apr 2010

Short-term calorie restriction improves function of T-cells

Scientists funded by the Agricultural Research Service (ARS) found that volunteers who followed a low-calorie diet or a very low-calorie diet not only lost weight, but also significantly enhanced their immune response. The study may be the first to demonstrate the interaction between calorie restriction and immune markers among humans.

30 Apr 2010

T Cell News and Research

Latest T Cell News and Research

DSM Biologics partners with Australian Governments to build cGMP mammalian CMO

Celgene seeks court declaration over claims of romidepsin injection usage for T-cell lymphomas

Roche's xCELLigence System helps study cell viability, cell death while testing cytotoxic compounds

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

Dieters who change their surroundings can easily adhere to diet: Researchers

Parents administering highly complex medication regimens require additional supports

PAS conference focuses on vaccine-preventable diseases among children

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

ZIOPHARM reports a net loss of $17.7 million in first quarter 2010

Researchers discover a new driving force behind cancer growth

Molecular imaging can help physicians identify aortic dissection: Research

Mutations in several genes associated with developmental brain disorder: Study

McGill scientist discovers how one particular gene regulates epithelial cells

Research shows microRNA can silence genes that protect genome from cancer-causing mutations

Accelerated radiotherapy improves overall survival of patient with NSCLC: Report

Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

Neuralstem's stem cell treatment for ALS featured on CNN with Dr. Sanjay Gupta

Stanford University's Herzenberg Lab wins 2010 Laureate in Computerworld Honors Program

Liver transplant recipients develop premature immune senescence: Researchers

Short-term calorie restriction improves function of T-cells

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in